Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13
Review
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,194 | Dovepress* | 5,767+ | 1,000 | 6,767 | |
| PubMed Central* | 2,427 | 553 | 2,980 | ||
| Totals | 8,194 | 1,553 | 9,747 | ||
| *Since 27 July 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar